Gregory Monteith

Gregory Monteith is a Professorial Research Fellow at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland. He leads the Calcium Signalling Therapeutics Team (CaSTT), focusing on cellular signaling in disease and drug target identification. His research integrates genetically encoded calcium indicators with high-throughput screening to develop therapies targeting calcium-mediated pathways in cancer. He holds grants from NHMRC, ARC, and international bodies, and has received awards for research excellence and supervision.

• Education: Bachelor (Honours) and PhD from the University of Sydney.
• Research Interests: Calcium regulation in disease, ion channels as drug targets, and high-throughput screening.
• Key Projects: High-content imaging platforms for drug discovery, breast cancer metastasis mechanisms, and viral infection calcium signaling.

His lab has developed FLIPR-Tetra systems for high-throughput calcium assays. Recent work includes studies on ORAI1, TMCO1, and PIEZO1 channels in cancer progression and drug resistance. He advises numerous PhD students and collaborates internationally on translational research.

Notable awards include the UQ Research Higher Degree Supervision Excellence Award (2016) and a Research Mentorship Award (2017). His work bridges basic science and clinical applications, with over 400 publications and patents in drug development.